RSS-Feed abonnieren

DOI: 10.1055/s-0043-1764464
Development of a New Process for Tulobuterol Hydrochloride
Autoren
Funding We are grateful to the China State Institute of Pharmaceutical Industry (CSIPI) and the Engineering Research Center for Improvement and Industrialization of Pharmaceutical Processes for the financial support. The work was also supported by Disha Pharmaceutical Group of China (Grant No. 2022CXGC020504).
Abstract
Tulobuterol is a selective β2-adrenoceptor agonist and has been widely utilized as a therapeutic agent for the treatment of asthma. Synthesis of tulobuterol has achieved many important progresses over the past decades and has gradually become one of the research hotspots in organic chemistry. This study aimed to explore a novel synthesis route to synthesize tulobuterol hydrochloride (1), an active ingredient of Chlobamolie Hydrochloride Tablets. In the study, 1 was obtained from the cost-effective, commercially available 2-chloroacetophenone through the key steps including the reactions of bromination, NaBH4 reduction, and amination. Process-related impurities were also investigated. 1 was obtained with excellent purity (99.96%) in 53% overall yield without the need for chromatographic purification. The developed method is green, facile, and cost-effective; thus, it is suitable for the industrial-scale production of 1.
# These two authors contributed equally to this work and should be considered co-first authors.
Supporting Information
1H NMR and 13C NMR spectra of compounds 3, 1, 6, 7, 8, 9, 10, and 11, as well as HPLC results for the purities of compounds 3 and 1, are included in the Supporting Information ([Figs. S1]–[S18] [online only]).
Publikationsverlauf
Eingereicht: 07. Dezember 2022
Angenommen: 15. Februar 2023
Artikel online veröffentlicht:
16. März 2023
© 2023. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)
Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany
-
References
- 1 Ge XY, Pan L, Wu YQ, An H, Cheng MS. Improved synthesis of tulobuterol [in Chinese]. Zhongguo Yaowu Huaxue Zazhi 2015; 25 (02) 112-114
- 2 Gernet A, Ratovelomanana-Vidal V, Pirat JL, Virieux D, Ayad T. Efficient synthesis of 2-amino-1-arylethanols through a Lewis base-catalyzed SiCl4-mediated asymmetric Passerini-type reaction. Eur J Org Chem 2020; 2020 (41) 6497-6500
- 3 Ranade VV. Synthesis of benzylic carbon-14 labelled tulobuterol-HCl. J Labelled Compd Rad 1984; 21 (04) 381-389
- 4 Fang J, Li Y, Zhao JJ. Comparison of efficacy and safety of tulobuterol hydrochloride and bambuterol hydrochloride in the treatment of children with bronchial asthma. Chin Sichuan Med 2013; 34 (10) 1531-1533
- 5 Kato H, Nagata O, Yamazaki M, Suzuki T, Nakano Y. Development of transdermal formulation of tulobuterol for the treatment of bronchial asthma [in Japanese]. Yakugaku Zasshi 2002; 122 (01) 57-69
- 6 Ge QH, Wang H, Wang XL, Zhi XJ, Zhou Z. Pharmacokinetics of tulobuterol patch in human [in Chinese]. Chinese Journal of Pharmaceuticals 2006; 37 (06) 407-410
- 7 Arakawa H, Adachi Y, Ebisawa M, Fujisawa T. Committee for Japanese Pediatric Guideline for Childhood Asthma, Japanese Society of Pediatric Allergy and Clinical Immunology, Japanese Society of Allergology. Japanese guidelines for childhood asthma 2020. Allergol Int 2020; 69 (03) 314-330
- 8 Kato H, Kurata S, Katsuyama F. α-(Alkylaminomethyl)-o-chlorobenzyl alcohols. DE Patent 2244737 A1, March 1973
- 9 Koshinaka E, Kurata S, Yamagishi K, Kubo S, Kato H. Synthesis and bronchodilating activity of o-chloro-α-(tert-butylaminomethyl)-benzylalcohol hydrochloride (C-78) and related compounds (author's transl) [in Japanese]. Yakugaku Zasshi 1978; 98 (09) 1198-1207
- 10 Marti HR, Gnehm R. Phenylethanolamines. EP Patent 0110202 A2, January 1984
- 11 Jing YJ, He SW, Guo W. Safe synthetic method of tulobuterol with low cost. CN Patent 105439875 A. March 2016
- 12 Glushkova MA, Popkov SV, Burdeinyi ML. Synthesis of the β2-agonist tulobuterol and its metabolite 4-hydroxytulobuterol. Russ J Org Chem 2020; 56 (03) 390-394
- 13 Saikia I, Borah AJ, Phukan P. Use of bromine and bromo-organic compounds in organic synthesis. Chem Rev 2016; 116 (12) 6837-7042
- 14 Xu S, Hao Q, Li H, Liu Z, Zhou W. Synthesis of trelagliptin succinate. Org Process Res Dev 2017; 21 (04) 585-589
- 15 Huang JX, Wang HY, Wu ZN, Zhang FL, Sun X. Improved synthesis of cenobamate [in Chinese]. Zhongguo Yaowu Huaxue Zazhi 2021; 31 (06) 419-421
